32.75
前日終値:
$32.11
開ける:
$32.25
24時間の取引高:
6.09M
Relative Volume:
1.40
時価総額:
$14.23B
収益:
$2.27B
当期純損益:
$1.15B
株価収益率:
12.84
EPS:
2.55
ネットキャッシュフロー:
$2.80B
1週間 パフォーマンス:
-0.21%
1か月 パフォーマンス:
+5.54%
6か月 パフォーマンス:
+23.49%
1年 パフォーマンス:
+15.81%
Royalty Pharma Plc Stock (RPRX) Company Profile
名前
Royalty Pharma Plc
セクター
電話
(212) 883-0200
住所
110 EAST 59TH STREET, NEW YORK, NY
RPRX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
RPRX
Royalty Pharma Plc
|
32.75 | 14.23B | 2.27B | 1.15B | 2.80B | 2.55 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
434.82 | 130.98B | 11.10B | -988.90M | -978.00M | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 64.65B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ARGX
Argen X Se Adr
|
622.93 | 39.39B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
276.55 | 34.32B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ONC
Beigene Ltd Adr
|
232.25 | 28.03B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-06-03 | ダウングレード | UBS | Buy → Neutral |
2022-06-14 | 再開されました | UBS | Buy |
2022-05-13 | 開始されました | Scotiabank | Sector Outperform |
2022-04-27 | 開始されました | Goldman | Buy |
2022-04-14 | アップグレード | JP Morgan | Neutral → Overweight |
2022-04-06 | 再開されました | Morgan Stanley | Overweight |
2021-10-29 | アップグレード | Citigroup | Neutral → Buy |
2021-07-30 | 開始されました | Tigress Financial | Buy |
2020-11-09 | アップグレード | UBS | Neutral → Buy |
2020-07-14 | 開始されました | Evercore ISI | In-line |
2020-07-13 | 開始されました | BofA Securities | Buy |
2020-07-13 | 開始されました | Citigroup | Neutral |
2020-07-13 | 開始されました | Cowen | Outperform |
2020-07-13 | 開始されました | Goldman | Neutral |
2020-07-13 | 開始されました | JP Morgan | Neutral |
2020-07-13 | 開始されました | Morgan Stanley | Equal-Weight |
2020-07-13 | 開始されました | SunTrust | Buy |
2020-07-13 | 開始されました | UBS | Neutral |
すべてを表示
Royalty Pharma Plc (RPRX) 最新ニュース
AQR Capital Management LLC Boosts Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
MML Investors Services LLC Takes Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Northern Trust Corp Acquires 376,619 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (RPRX) Reports Q1: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by ArrowMark Colorado Holdings LLC - MarketBeat
Royalty Pharma (RPRX) Projected to Post Earnings on Thursday - MarketBeat
PDT Partners LLC Grows Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Hsbc Holdings PLC Sells 30,304 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Unlocking Q1 Potential of Royalty Pharma (RPRX): Exploring Wall Street Estimates for Key Metrics - Nasdaq
AlTi Global Inc. Purchases New Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Caisse DE Depot ET Placement DU Quebec Invests $18.18 Million in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Holdings Boosted by Regal Partners Ltd - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Tudor Investment Corp ET AL - MarketBeat
First Trust Advisors LP Decreases Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Wells Fargo & Company MN Buys 15,790 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Moody’s upgrades Royalty Pharma’s rating, maintains stable outlook By Investing.com - Investing.com Nigeria
Moody’s upgrades Royalty Pharma’s rating, maintains stable outlook - Investing.com Australia
Walleye Capital LLC Buys Shares of 25,124 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Uniplan Investment Counsel Inc. Buys New Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Dark Forest Capital Management LP - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Bought by GMT Capital Corp - MarketBeat
Barclays PLC Acquires 54,421 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Declares $0.22 Quarterly Dividend - MarketBeat
Brokerages Set Royalty Pharma plc (NASDAQ:RPRX) Price Target at $42.50 - MarketBeat
Cerity Partners LLC Sells 15,537 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Canada Pension Plan Investment Board Buys 39,070 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Guggenheim Capital LLC Sells 82,768 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Adage Capital Partners GP L.L.C. - MarketBeat
Raymond James Financial Inc. Buys Shares of 783,633 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Jump Financial LLC Makes New $2.09 Million Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Invesco Ltd. Raises Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Bridgewater Associates LP Acquires New Stake in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma PLC (RPRX) Surged Following an Acquisition Announcement - Insider Monkey
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Synovus Financial Corp - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Ontario Teachers Pension Plan Board - MarketBeat
Royalty Pharma Plc (RPRX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):